Short answer · Medically reviewed summary · Last updated: 2026-04-07
Waldenström macroglobulinemia is officially classified as lymphoplasmacytic lymphoma (LPL) with IgM monoclonal gammopathy, though it is most commonly referred to by its eponymous name in clinical settings. Common Synonyms and Historical Nomenclature While Waldenström macroglobulinemia is the standard term used globally, you may encounter several alternative names in older medical literature or international records. These include: Lymphoplasmacytic lymphoma (the current WHO classification term) Waldenström's disease Primary macroglobulinemia Essential hyperglobulinemic purpura (a historical term rarely used today) IgM-secreting lymphoplasmacytic lymphoma The name Waldenström macroglobulinemia honors the Swedish physician Jan G.
Waldenstrom Macroglobulinemia synonyms
Other names for Waldenstrom Macroglobulinemia: synonyms, acronyms and related terms used by doctors and patients.
Waldenström macroglobulinemia is officially classified as lymphoplasmacytic lymphoma (LPL) with IgM monoclonal gammopathy, though it is most commonly referred to by its eponymous name in clinical settings.
Common Synonyms and Historical Nomenclature
While Waldenström macroglobulinemia is the standard term used globally, you may encounter several alternative names in older medical literature or international records. These include:
- Lymphoplasmacytic lymphoma (the current WHO classification term)
- Waldenström's disease
- Primary macroglobulinemia
- Essential hyperglobulinemic purpura (a historical term rarely used today)
- IgM-secreting lymphoplasmacytic lymphoma
The name Waldenström macroglobulinemia honors the Swedish physician Jan G. Waldenström, who first described the condition in 1944. Historically, it was sometimes conflated with other gammopathies, but as our understanding of the underlying molecular biology—specifically the MYD88 mutation—has evolved, the medical community has refined the terminology to better reflect its nature as a type of B-cell lymphoma.
Classification Systems
Different medical authorities categorize the condition to ensure consistency in research and clinical reporting:
- Orphanet: Lists the disease as Waldenström macroglobulinemia (ORPHA:547).
- OMIM: Identifies the condition under #153600, noting its complex genetic underpinnings.
- ICD-10/11: Categorized under lymphoplasmacytic lymphoma, reflecting its inclusion as a distinct subtype of non-Hodgkin lymphoma.
Why Multiple Names Exist
The variety of names for Waldenström macroglobulinemia stems from the shift from descriptive naming (based on the presence of large "macro" proteins found in the blood) to pathological classification (based on the type of lymphoma cells present). Today, the most preferred term among hematologists and oncologists remains Waldenström macroglobulinemia, though clinical pathology reports will almost always specify "lymphoplasmacytic lymphoma" to align with international cancer staging and treatment protocols.
Medical Disclaimer: This information is provided for educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions regarding your specific medical condition or treatment plan.
References
- Orphanet (ORPHA:547): Waldenström macroglobulinemia
- NIH Genetic and Rare Diseases Information Center (GARD): Waldenström macroglobulinemia
- OMIM (Online Mendelian Inheritance in Man): #153600, Lymphoplasmacytic Lymphoma
- International Waldenstrom's Macroglobulinemia Foundation (IWMF)
